CClinicalTrials.gg
CompletedNCT04291807Updated Mar 2, 2020

Video Assisted Education Before ERCP

An interventional study of Video education in Patient Compliance, sponsored by Istanbul Medipol University Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2020-03-02.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Sep 2017, registered Feb 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

It was aimed to study the effect of video assisted education about endoscopic retrograde cholangiopancreaticography (ERCP) on anxiety levels of patients who planned to undergo ERCP for any reason.Video revealing the ERCP procedure was shown to the patients in one group and not shown to the other. Then anxiety levels and pain scores have been obtained before and after the procedure in both groups

Read the detailed description

The study was conducted to determine the effect of video education on anxiety level before the ERCP procedure and satisfaction degree after the ERCP procedure between September 1st 2017 and December 31st 2018 at Bagcilar Medipol Mega University Hospital. Patients were grouped into two in a randomized manner. In control arm, patients underwent ERCP procedure with the information provided by the gastroenterologist who recommended the procedure. Patients in experimental arm, besides the information provided by the gastroenterologist, watched video of ERCP procedure and answered all the questions about the procedure by an experienced nurse. A total of 70 patients (35 in each arms) was planned to enroll to the study. State-Trait Anxiety Inventory (STAI) form was applied to measure anxiety level and visual analog score (VAS) was applied to measure the satisfaction about the procedure.

02

Conditions studied

  • Patient Compliance

Keywords

  • video education
  • ERCP
  • anxiety level
  • pain score
03

In context

Lead sponsor

Istanbul Medipol University Hospital is the lead sponsor of 350 studies on the registry; 58 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Over 18 years old
  • Conscious enough to understand the procedure and education
  • Patients who can read
  • Hemodynamically stable patients
  • Mentally stable patients
  • Patients who gave informed consent

Exclusion criteria

Exclusion Criteria:

  • Patients who underwent previous ERCP procedure
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Video education

    A video of ERCP procedure has been viewed to the patients who will undergo ERCP and questions about the procedure had been answered by the primary investigator (experienced endoscopy nurse)

    Behavioral: Video education

  • No intervention
    Direct ERCP

    Patients arranged ERCP for any reason underwent directly to the ERCP without any video education.

Interventions

  • BehavioralVideo education

    Procedure was presented to the cases via a video showing the steps in ERCP and questions had been answered by an experienced nurse

06

What researchers measure

Primary outcomes

  1. Change in anxiety status of the patients after ERCP

    This will be measured with Stait Trait Anxiety Inventory. There are 2 subscales within this measure. The State Anxiety Scale (S-Anxiety) evaluates the current state of anxiety, asking how respondents feel "right now," using items that measure subjective feelings of apprehension, tension, nervousness, worry, and activation/arousal of the autonomic nervous system. The Trait Anxiety Scale (T-Anxiety) evaluates relatively stable aspects of "anxiety proneness," including general states of calmness, confidence, and security. The STAI has 40 items, 20 items allocated to each of the subscales. Responses for the S-Anxiety scale assess intensity of current feelings "at this moment": 1) not at all, 2) somewhat, 3) moderately so, and 4) very much so. Responses for the T-Anxiety scale assess frequency of feelings "in general": 1) almost never, 2) sometimes, 3) often, and 4) almost always. Range of scores for each subtest is 20-80, the higher score indicating greater anxiety.

    Time frame: an hour before ERCP and an hour after ERCP

Secondary outcomes

  1. Satisfaction assessed by visual analogue scale

    A VAS for satisfaction is a horizontal line of 100-mm long. At the beginning and at the end, there are two descriptors representing extremes of satisfaction (i.e. no satisfaction and extreme satisfaction). The patient rated his satisfaction by making a vertical mark on the 100-mm line. The measurement in millimetres was converted to the same number of points ranging from 0 to 100 points.

    Time frame: an hour after ERCP

07

Study locations

1 site
  • Istanbul Medipol University
    Istanbul, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04291807
Lead sponsor
Istanbul Medipol University Hospital
Responsible party
leylacevik (Research Nurse, Istanbul Medipol University Hospital) — Principal investigator
First posted
Mar 2, 2020
Start date
Sep 1, 2017
Primary completion
Dec 31, 2018
Completion
Aug 7, 2019
Last update
Mar 2, 2020

Study contacts

Leyla Cevik, RN
principal investigator · Medipol University
Selda Rızalar, Assoc Prof
study chair · Medipol University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion